Multiple Myeloma section

Multiple Myeloma News & Features

Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma

Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma

Researchers report on their findings of a retrospective study that compared pomalidomide plus dexamethasone vs dexamethasone alone in patients with relapsed/refractory multiple myeloma.

Common Oncologic Emergencies That Occur With Multiple Myeloma

Common Oncologic Emergencies That Occur With Multiple Myeloma

What are the common oncologic emergencies seen in patients with MM?

Multiple Myeloma Survival Decreased With High ADAR1 RNA Expression

Multiple Myeloma Survival Decreased With High ADAR1 RNA Expression

ADAR1 knockdown reduces regeneration of high-risk multiple myeloma in patient-derived xenografts

Carfilzomib Associated With Cardiovascular Adverse Events in Multiple Myeloma

Carfilzomib Associated With Cardiovascular Adverse Events in Multiple Myeloma

For this meta-analysis and systematic review, investigators compiled phase 1 to 3 prospective clinical trials of carfilzomib therapy for patients with MM that had evaluable toxic effects data.

No Increased Risk for Melanoma in Patients With MM

No Increased Risk for Melanoma in Patients With MM

An increased prevalence of melanoma has been observed in patients with various immunocompromised conditions.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs